Electrophysiological study and 'slow' ventricular tachycardia predict appropriate therapy: Results from a single-centre implantable cardiac defibrillator follow-up

Europace

Volumn 9, Issue 11, 2007, Pages 1048-1053

  Worck, René ^a   Haarbo, Jens ^b   Thomsen, Poul Erik Bloch ^b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Appropriate therapy; Cardiac death; Electrophysiology study; ICD; Inappropriate therapy

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; VERAPAMIL; ANTIARRHYTHMIC AGENT;

AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEFIBRILLATION; FEMALE; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HEART FUNCTION TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROPATHY; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL RATE; DEFIBRILLATOR; ELECTROPHYSIOLOGY; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; RISK FACTOR; SUDDEN DEATH; TREATMENT OUTCOME;

ACCELERATED IDIOVENTRICULAR RHYTHM; AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROPHYSIOLOGY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME;

EID: 40049112637     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum154     Document Type: Article

References (16)

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation 2006;114:1088-1132.
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
4. Nielsen J, Mortensen P, Pedersen A. Long term follow-up of patients treated with implantable cardioverter defibrillators in a Danish centre. Scand Cardiovasc J 1997;31:151-6.
5. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation 2000;101:1660-4.
6. Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol 2005;46:1712-20.
7. Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, deSousa M et al. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study. Europace 2006;8:618-24.
8. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Patients. J Am Coll Cardiol 2006;47:98-107.
9. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004;43:1459-65.
10. Altman DG. Analysis of survival times. Practical Statistics for Medical Research. London: Chapman & Hall; 1991.
11. Tandri H, Griffith LS, Tang T, Nasir K, Zardkoohi O, Reddy CV et al. Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. Heart Rhythm 2006;3:762-8.
12. Smit MD, Van Dessel PFHM, Rienstra M, Nieuwland W, Wiesfeld ACP, Tan ES et al. Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients. Europace 2006;8:566-72.
13. Khalighi MD, Daly MD, Leino PEV, Shorofsky MD. Clinical predictors of transvenous defibrillation energy requirements. Am J Cardiol 1997;79:150-3.
14. Zhou L, Chen BP, Kluger J, Fan C, Chow MSS. Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold. J Am Coll Cardiol 1998;31:1672-8.
15. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the Detect Supraventricular Tachycardia Study. Circulation 2006;113:2871-9.
16. Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Conundrum. Circulation 2004;110:1885-9.